poisar

Stock

Pulmonx Corporation LUNG

$2.16-5.68%

Overview

LUNG market data

Price History

LUNG price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.33
Diluted earnings per share over the trailing twelve months.
Beta
0.31
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-55.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.13 – $2.89
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $97.9M · P/B 1.68 · P/S 1.12.

Company News

4 captured
Pulmonx shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Jul 29, 2026, 8:47 PM
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M EstBenzinga · Jul 29, 2026, 8:15 PM
8-K filing — Pulmonx Corp (LUNG)SEC EDGAR · Jul 29, 2026, 8:07 PM
Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M EstimateBenzinga · Jul 29, 2026, 8:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock